Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proton vs Photon Therapy in Esophageal Cancer
NCT03234842Phase 2Withdrawn
- Sponsor
- University of Florida
- Start
- Oct 2017
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 2, open-label trial (2 arms), sponsored by University of Florida. Primary endpoint: Decrease in Diffusion Lung Capacity of Carbon Monoxide at 12 months. Planned start Oct 2017; status: withdrawn.
Beyond the preview
Go deeper on NCT03234842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03234842.